Tags

Type your tag names separated by a space and hit enter

HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China.
Vaccine. 2020 03 23; 38(14):3021-3030.V

Abstract

OBJECTIVE

This study aims to investigate acceptance and willingness to pay for HPV vaccination among adult women in China.

METHODS

An online survey was sent to mothers aged 27-45 years of primary school pupils in the Fujian province, China. Participants completed questions about HPV related knowledge and health beliefs, intention to take the HPV vaccine and the willingness to pay for bivalent vaccine (2vHPV), quadrivalent vaccine (4vHPV), and 9-valent HPV vaccine (9vHPV).

RESULTS

Of a total of 2339 complete responses, 58.3% reported intent to obtain HPV vaccine. Mothers who were younger in age, residing in urban, working in managerial or professional occupations, who knew someone with cervical cancer and who were able to make independent decisions about the HPV vaccine (vs. joint decision with spouse) were more likely to express intent to have HPV vaccination. Perceived barriers, cues to action and self-efficacy were three of the constructs in the health belief model that significantly influenced HPV vaccination intent. A higher proportion of participants expressed willingness to pay for 2vHPV (81.2%) and 4vHPV (75.9%), as compared to 9vHPV (67.7%).

CONCLUSION

Adults women expressed moderate intention to receive the HPV vaccine. Intervention to address barriers to uptake of the HPV vaccine among adult women in China is warranted.

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Lin Y
Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, Fujian Province, China; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou 350122, Fujian Province, China.
Lin Z
Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, Fujian Province, China; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou 350122, Fujian Province, China.
He F
Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, Fujian Province, China; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou 350122, Fujian Province, China.
Chen H
Department of Radiation Oncology, Anxi County Hospital, Quanzhou 352400, Fujian Province, China.
Lin X
Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou 363000, Fujian Province, China.
Zimet GD
Department of Pediatrics, School of Medicine, Indiana University, 410 W, 10th St., HS 1001, Indianapolis, IN 46202, United States.
Alias H
Centre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.
He S
Prenatal Diagnosis Center, Fujian Provincial Maternity and Children's Hospital of Fujian Medical University, Fuzhou 350001, Fujian Province, China.
Hu Z
Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, Fujian Province, China; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou 350122, Fujian Province, China. Electronic address: huzhijian@fjmu.edu.cn.
Wong LP
Centre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia. Electronic address: wonglp@ummc.edu.my.

MeSH

AdultChinaFemaleHealth Knowledge, Attitudes, PracticeHumansIntentionMiddle AgedMothersPapillomavirus InfectionsPapillomavirus VaccinesPatient Acceptance of Health CareSurveys and QuestionnairesUterine Cervical NeoplasmsVaccination

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32127227

Citation

Lin, Yulan, et al. "HPV Vaccination Intent and Willingness to Pay for 2-,4-, and 9-valent HPV Vaccines: a Study of Adult Women Aged 27-45 Years in China." Vaccine, vol. 38, no. 14, 2020, pp. 3021-3030.
Lin Y, Lin Z, He F, et al. HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China. Vaccine. 2020;38(14):3021-3030.
Lin, Y., Lin, Z., He, F., Chen, H., Lin, X., Zimet, G. D., Alias, H., He, S., Hu, Z., & Wong, L. P. (2020). HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China. Vaccine, 38(14), 3021-3030. https://doi.org/10.1016/j.vaccine.2020.02.042
Lin Y, et al. HPV Vaccination Intent and Willingness to Pay for 2-,4-, and 9-valent HPV Vaccines: a Study of Adult Women Aged 27-45 Years in China. Vaccine. 2020 03 23;38(14):3021-3030. PubMed PMID: 32127227.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China. AU - Lin,Yulan, AU - Lin,Zheng, AU - He,Fei, AU - Chen,Huilin, AU - Lin,Xi, AU - Zimet,Gregory D, AU - Alias,Haridah, AU - He,Shuqiong, AU - Hu,Zhijian, AU - Wong,Li Ping, Y1 - 2020/02/29/ PY - 2019/11/17/received PY - 2020/02/13/revised PY - 2020/02/15/accepted PY - 2020/3/5/pubmed PY - 2021/4/10/medline PY - 2020/3/5/entrez KW - 2-, 4- and 9-valent HPV vaccines KW - Adult women KW - China KW - HPV vaccination intention SP - 3021 EP - 3030 JF - Vaccine JO - Vaccine VL - 38 IS - 14 N2 - OBJECTIVE: This study aims to investigate acceptance and willingness to pay for HPV vaccination among adult women in China. METHODS: An online survey was sent to mothers aged 27-45 years of primary school pupils in the Fujian province, China. Participants completed questions about HPV related knowledge and health beliefs, intention to take the HPV vaccine and the willingness to pay for bivalent vaccine (2vHPV), quadrivalent vaccine (4vHPV), and 9-valent HPV vaccine (9vHPV). RESULTS: Of a total of 2339 complete responses, 58.3% reported intent to obtain HPV vaccine. Mothers who were younger in age, residing in urban, working in managerial or professional occupations, who knew someone with cervical cancer and who were able to make independent decisions about the HPV vaccine (vs. joint decision with spouse) were more likely to express intent to have HPV vaccination. Perceived barriers, cues to action and self-efficacy were three of the constructs in the health belief model that significantly influenced HPV vaccination intent. A higher proportion of participants expressed willingness to pay for 2vHPV (81.2%) and 4vHPV (75.9%), as compared to 9vHPV (67.7%). CONCLUSION: Adults women expressed moderate intention to receive the HPV vaccine. Intervention to address barriers to uptake of the HPV vaccine among adult women in China is warranted. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/32127227/HPV_vaccination_intent_and_willingness_to_pay_for_2_4__and_9_valent_HPV_vaccines:_A_study_of_adult_women_aged_27_45_years_in_China_ DB - PRIME DP - Unbound Medicine ER -